Skip to search formSkip to main contentSkip to account menu

vilazodone

Known as: Vilazodonum, Vilazodona, 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}benzofuran-2-carboxamide 
A selective serotonin (5-HT) reuptake inhibitor (SSRI) and a 5-HT-1A receptor partial agonist, with antidepressant and anti-anxiety activities… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Viibryd
vilazodone hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis.
2016
2016
Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study
The aim of this study is to evaluate the effects of vilazodone on sexual functioning in healthy, sexually active adults and… 
2016
2016
Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
OBJECTIVE To evaluate the efficacy, safety, and tolerability of vilazodone as an acute treatment for generalized anxiety disorder… 
2015
2015
Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial
Sexual dysfunction commonly occurs with major depressive disorder (MDD). Vilazodone, a selective serotonin reuptake inhibitor and… 
Review
2015
Review
2015
Prescriber's Guide to Using 3 New Antidepressants: Vilazodone, Levomilnacipran, Vortioxetine
[ILLUSTRATION OMITTED] How do they work? What makes them different? And which patients might benefit most from taking them? With… 
2015
2015
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder.
INTRODUCTION Vilazodone, a selective and potent 5-HT1A partial agonist and 5-HT reuptake inhibitor, has been approved for… 
2014
2014
Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor
ISSUE:Vilazodone is an antidepressant with a novel mechanism of pharmacologic action: serotonin partial agonist reuptake… 
Review
2014
Review
2014
A Review of Vilazodone, Serotonin, and Major Depressive Disorder
Objective: To review the mechanism of selective serotonin reuptake inhibitor (SSRI)–mediated serotonergic neurotransmission… 
2013
2013
Pharmacokinetics of Vilazodone in Patients with Mild or Moderate Renal Impairment
Background and ObjectiveIn patients with impaired renal function, the pharmacokinetics of a drug may be altered, resulting in… 
2004
2004
Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)